Abstract
Introduction: Advances in cystic fibrosis (CF) therapy have resulted in improved survival and increasing treatment burden and costs. The economic impact of current treatment strategies for CF is poorly defined. Methods: The authors prospectively assessed direct medical costs (including hospitalizations, outpatient interventions, drugs, devices, dietetic products) in 165 consecutive CF patients (aged 5-39 years) seen between March and July 2009. Results: The mean annual cost/patient increased with age and lung disease severity from €4,164 in children aged 5 years to €30,123 in patients aged >5 years with severe lung disease (forced expiratory volume in 1 second [FEV1]
| Original language | English |
|---|---|
| Pages (from-to) | 165-175 |
| Number of pages | 11 |
| Journal | Advances in Therapy |
| Volume | 30 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 2013 |
Keywords
- Cystic fibrosis
- Forced expiratory volume
- Healthcare costs
- Lung disease
- Respiratory
ASJC Scopus subject areas
- Pharmacology (medical)
- Medicine(all)
Fingerprint Dive into the research topics of 'Cost of cystic fibrosis: Analysis of treatment costs in a specialized center in Northern Italy'. Together they form a unique fingerprint.
Cite this
Colombo, C., Daccò, V., Alicandro, G., Loi, S., Mazzi, S., Lucioni, C., & Ravasio, R. (2013). Cost of cystic fibrosis: Analysis of treatment costs in a specialized center in Northern Italy. Advances in Therapy, 30(2), 165-175. https://doi.org/10.1007/s12325-013-0008-5